The relative contributions of antithrombin iii during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.

A. S. Gallus, K. T. Goodall, J. Tillett, J. Jackaman, A. Wycherley

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The relative contributions of antithrombin iii during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.'. Together they form a unique fingerprint.

Medicine & Life Sciences